Skip to main content
SpringerLink
Log in
Book cover

Understanding the Global Dimensions of Health pp 133–146Cite as

Critical Inquiries on Technology Utilization

  • Chapter

Abstract

The emergence and diffusion of various types of health care technologies over the last two decades has been characterized by unprecedented vigor in development and proliferation. The degree to which such interventions have been embraced in the ‘rational’ health care environment of developed countries is hardly less than astonishing, given that the great majority have received little or no examination to scientific standards, which might demonstrate benefits or risks to health.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson, K.M., Odell, P.M., Wilson, P.W.F., & Kannel, W.B. (1990). Cardiovascular disease risk profiles. American Heart Journal, 121, 293–8.

    Article  Google Scholar 

  • Barlow, D., Cooper, C., Reeve, J., & Reid, D. (1996, February). Department of health is fair to patients with osteoporosis. British Medical Journal, 312, 297–8.

    Google Scholar 

  • Bassett, K. (1996). Anthropology, clinical pathology and the electronic fetal monitor: Lessons from the heart. Social Science and Medicine, 42(2), 281–92.

    Article  PubMed  CAS  Google Scholar 

  • Bassett, K., & Kazanjian, A. (1996). Incorporating clinical effectiveness debates into hospital technology assessment: The case of laser treatment of benign prostatic hyperplasia. Vancouver, BC: British Columbia Office of Health Technology Assessment.

    Google Scholar 

  • British Columbia Council on Clinical Practice Guidelines (1996). Cholesterol testing. Vancouver (BC): The Council.

    Google Scholar 

  • Brown, J., & Kerns, V. (1985). In her prime: A new view of middle-aged women. Massachusetts: Bergin and Garvey.

    Google Scholar 

  • Coupland, D., Lentle, B., Aldrich, J., Connell, D., & Janzen, D. (1996). Recommendations for the measurement and quantification of bone mineral density. British Columbia Medical Journal, 38(5), 265–8.

    Google Scholar 

  • Cullen P, & Assmann, G. (1997). Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: Absolute levels or extent of lowering? The American Journal of Cardiology, 80, 1287–94.

    Article  PubMed  CAS  Google Scholar 

  • D’Amico, A.V., Chen, M.H., Roehl, K.A., & Catalona, W. (2004). Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. New England Journal of Medicine, 351(2), 125–35.

    Article  PubMed  CAS  Google Scholar 

  • Featherstone, M., & Hepworth, M. (1991). The mask of ageing and the postmodern life course. In M. Featherstone, M. Hepworth, & B.S Turner (Eds.), The body: Social process and cultural theory (pp. 371–389). London: Sage.

    Google Scholar 

  • Gifford, S. (1986). The meaning of lumps: A case study of the ambiguities of risk. In C.R. Janes, R. Stall, & S.M. Gifford (Eds.), Anthropology and epidemiology: Interdisciplinary approaches to the study of health and disease (pp. 213–246). Dordrecht: Reidel.

    Google Scholar 

  • Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Englewood Cliffs, NJ: Prentice-Hall.

    Google Scholar 

  • Green, C.J., Hadom, D., Bassett, K., & Kazanjian, A. (1992, September). Prostate specific antigen in the early detection of prostate cancer. Vancouver, BC: British Columbia Office of Health Technology Assessment.

    Google Scholar 

  • Green, C.J., Bassett, K., Foerster, V., & Kazanjian, A. (1997). Bone mineral density testing: Does the evidence support its selective use in well women? Vancouver, BC: British Columbia Office of Health Technology Assessment.

    Google Scholar 

  • Green, C.J., Gallagher, R.P., & Kazanjian, A. (1999). A population-based study of the relationship between prostate specific antigen testing utilization rates and patterns of prostate cancer incidence and mortality. Vancouver, BC: British Columbia Office of Health Technology Assessment.

    Google Scholar 

  • Grundy, S.M. (1998). Statin trails and goals for cholesterol lowering therapy. Circulation, 97, 1436–9.

    PubMed  CAS  Google Scholar 

  • Hailey, D., Sampietro-Colom, L., Marshall, D., Rico, P., Granados, A., Asua, J., et al. (1996). Statement of findings. INAHATA project on the effectiveness of bone density measurement and associated treatments for prevention of fractures. Edmonton, AB: Alberta Heritage Foundation for Medical Research.

    Google Scholar 

  • Haraway, D. (1990). A manifesto for cyborgs: Science, technology, and socialist feminism in the 1980s. In L.J. Nicholson (Ed.), Feminism/Postmodernism (pp. 65–107). London: Routledge.

    Google Scholar 

  • Health Services Utilization and Research Commission. (1995). Cholesterol testing and treatment guidelines. Saskatoon, SK: The Commission.

    Google Scholar 

  • Hubbard, R. (1990). The politics of women’s biology. New Brunswick: Rutgers University Press.

    Google Scholar 

  • Kaufert, P. (1998). Menopause as process or event: The creation of definitions in biomedicine. In M. Lock & D. Gordon (Eds.), Biomedicine examined (pp. 341–49). Dordrecht/Boston/London: Kluwer.

    Google Scholar 

  • Kaufert, P. (1982). Myth and the menopause. Sociology of Health and Illness, 4, 141–66.

    Article  Google Scholar 

  • Kaufert, P., & Gilbert, P. (1986). Women, menopause, and medicalization. Culture, Medicine and Psychiatry, 10, 7–21.

    Article  PubMed  CAS  Google Scholar 

  • Kazanjian, A., Cardiff, K., & Pagliccia, N. (1995). Design and development of a conceptual and quantitative framework for health technology decisions: A multi-project compendium of research underway. British Columbia Office of Health Technology Assessment.

    Google Scholar 

  • Koenig, B. (1998). The technological imperative in medical practice: The social creation of a “routine” treatment. In M. Lock & D. Gordon (Eds.), Biomedicine examined (pp. 465–496). Dordrecht/Boston/London: Kluwer.

    Google Scholar 

  • Kunisch, J.R. (1989). Electronic fetal monitors: Marketing forces and the resulting controversy. In K. S. Ratcliffe (Ed.), Healing technology: Feminist perspectives (pp. 41–60). Ann Arbor: University of Michigan Press.

    Google Scholar 

  • Lock, M. (1993). Encounters with aging: Mythologies of menopause in Japan and North America. Berkeley and Los Angeles: University of California Press.

    Google Scholar 

  • Lock, M. (1996, November). Social and cultural issues in connection with breast cancer testing and screening. Genetic testing for breast cancer susceptibility: The science, the ethics, the future. Paper presented at International Bioethics Conference, San Francisco.

    Google Scholar 

  • Logan, A.G. (1994). Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on Periodic Health Examination. Canadian guide to preventive health. Ottawa, ON. Canada Communication Group.

    Google Scholar 

  • Marshall D., Sheldon T.A., & Jonsson, E. (1997). Recommendations for the application of bone density measurement: What can you believe? International Journal of Technology Assessment in Health Care, 13(3), 411–19.

    Article  PubMed  CAS  Google Scholar 

  • Marshall, K. (1996). Prevention. How much harm? How much benefit? Physical, psychological and social harm. Canadian Medical Association Journal, 155(2), 169–176.

    PubMed  CAS  Google Scholar 

  • Martin, E. (1991). The egg and the sperm: How science has constructed a romance based on male and female roles. Signs, 16(3), 485–501.

    Article  Google Scholar 

  • McKinlay, S., Brambilla, D., & Posner, J. (1992). The normal menopausal transition. Human Biology, 4, 37–46.

    Article  Google Scholar 

  • Mintzes, B. (1998). Blurring the boundaries: New trends in drug promotion. Health Action International-Europe.

    Google Scholar 

  • Nelkin, D. (1996). The social dynamics of genetic testing: The case of Fragile-X. Medical Anthropology Quarterly, 10(4), 537–550.

    Article  PubMed  CAS  Google Scholar 

  • Parsons, T. (1967). The structure of social action: a study in social theory with special reference to a group of recent European writers (2nd ed.). New York: Free Press; London: Collier-Macmillan.

    Google Scholar 

  • Posner, T. (1991). What’s in a smear? Cervical screening, medical signs and metaphors. Science as Culture, 2(2), 167–87.

    Article  Google Scholar 

  • Rapp, R. (1995). Real time fetus: The role of the sonogram in the age of mechanical reproduction. In G.L. Downey, J. Dumit & S. Traweek (Eds.), Cyborgs and citadels: Anthropological interventions in the borderlands of technoscience (pp. 32–64). Seattle: University of Washington Press.

    Google Scholar 

  • Ringertz, H., Marshall D., Johansson C., Johnell O., Kullenberg R.J., Ljunghall S. & et al. (1997). Bone density measurement: A systematic review. A report from SBU, The Swedish Council on Technology Assessment in Health Care. Journal of Internal Medicine, 241(suppl 739):i–iii, 1–60.

    Google Scholar 

  • Rosengren, A. (1998). Cholesterol: How low is low enough? Reaching target levels may be better than relative reductions. British Medical Journal, 317, 426–7.

    Google Scholar 

  • Savoie I., Bassett K., & Kazanjian, A. (1997, August). Supporting clinical practice guidelines development: An appraisal of existing cholesterol testing guidelines. Vancouver, BC: BC Office of Health Technology Assessment.

    Google Scholar 

  • Savoie I., Kazanjian, A. (1999). Will it change patient management? What we really get from cholesterol testing. Vancouver, BC: BC Office of Health Technology Assessment.

    Google Scholar 

  • Shiva, V., & Moser, I. (1995). Biopolitics: A feminist and ecological reader on biotechnology. London; Atlantic Highlands.

    Google Scholar 

  • Skrabanek, P. (1985). False premises and false promises of breast cancer screening. The Lancet, 2, 316–320.

    Article  CAS  Google Scholar 

  • Strother Ratcliffe, K. (1989). Health technologies for women: Whose health? Whose technology? In K. S. Ratcliffe (Ed.), Healing technology: Feminist perspectives (pp. 173–198). Ann Arbor: University of Michigan Press.

    Google Scholar 

  • Wald N.J., Law, M, Watt H.C., Wu,T, Bailey, A, Johnson, A.M., & et al. (1994). Apolipoproteins and ischemic heart disease: Implications for screening. The Lancet, 343, 75–79.

    Article  CAS  Google Scholar 

  • Whatley, M.H., & Worcester, N. (1989). The role of technology in the co-optation of the women’s health movement: The cases of osteoporosis and breast cancer. In K. S. Ratcliffe (Ed.), Healing technology: Feminist perspectives (pp. 199–220). Ann Arbor: University of Michigan Press.

    Google Scholar 

  • WHO Study Group. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva, Switzerland: World Health Organization.

    Google Scholar 

  • Working Group on Hypercholesterolemia and Other Dyslipidemias. (1997, March). Detection and management of hypercholesterolemia (Interim report).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Health Care and Epidemiology, Faculty of Medicine, University of British Columbia, Vancouver, Canada

    Arminée Kazanjian (Professor)

Authors
  1. Arminée Kazanjian
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. International Association for Humanitarian Medicine Brock Chisholm, La Panetiere, Bogis-Bossey, 1279, Switzerland

    S. W. A. Gunn

  2. World Health Organization, Geneva, Switzerland

    P. B. Mansourian  & A. Piel  & 

  3. Hebrew University of Jerusalem, Jerusalem, Israel

    A. M. Davies

  4. Imperial College of Science, Technology, and Medicine, London, UK

    B. McA. Sayers

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Kazanjian, A. (2005). Critical Inquiries on Technology Utilization. In: Gunn, S.W.A., Mansourian, P.B., Davies, A.M., Piel, A., Sayers, B.M. (eds) Understanding the Global Dimensions of Health. Springer, Boston, MA. https://doi.org/10.1007/0-387-24103-5_9

Download citation

  • DOI: https://doi.org/10.1007/0-387-24103-5_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-24102-9

  • Online ISBN: 978-0-387-24103-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation